Quick Answer
OPKO HEALTH, INC. reported Research And Development Expense of $124.03 million for the year ending 2025.
- OPKO HEALTH, INC. showed an increase of +17.9% in Research And Development Expense from 2024 to 2025.
- This data is from OPKO HEALTH, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $1.58 million | Q3 2010: $1.54 million | Q1 2011: $1.09 million | Q2 2011: $2.71 million | Q3 2011: $3.30 million | Q1 2012: $4.83 million | Q2 2012: $4.49 million | Q3 2012: $3.62 million | Q1 2013: $9.91 million | Q2 2013: $9.56 million | Q3 2013: $11.09 million | Q1 2014: $20.99 million | Q2 2014: $16.23 million | Q3 2014: $20.52 million | Q1 2015: $25.50 million | Q2 2015: $29.57 million | Q3 2015: $18.94 million | Q1 2016: $27.82 million | Q2 2016: $31.35 million | Q3 2016: $24.42 million | Q1 2017: $26.56 million | Q2 2017: $33.13 million | Q3 2017: $32.51 million | Q1 2018: $32.89 million | Q2 2018: $29.21 million | Q3 2018: $30.16 million | Q1 2019: $36.53 million | Q2 2019: $28.29 million | Q3 2019: $30.02 million | Q1 2020: $21.76 million | Q2 2020: $17.61 million | Q3 2020: $18.49 million | Q1 2021: $19.32 million | Q2 2021: $18.22 million | Q3 2021: $18.31 million | Q1 2022: $18.31 million | Q2 2022: $17.25 million | Q3 2022: $18.79 million | Q1 2023: $32.61 million | Q2 2023: $18.16 million | Q3 2023: $19.44 million | Q1 2024: $21.94 million | Q2 2024: $24.08 million | Q3 2024: $28.77 million | Q1 2025: $30.84 million | Q2 2025: $30.34 million | Q3 2025: $30.08 million.
- Over the full 17 years of available data (2009 to 2025), OPKO HEALTH, INC.'s Research And Development Expense has grown by 1,044.6%.
- Historical annual values: Fiscal year 2025: $124.03 million | Fiscal year 2024: $105.21 million | Fiscal year 2023: $89.59 million | Fiscal year 2022: $73.89 million | Fiscal year 2021: $76.85 million | Fiscal year 2020: $75.32 million | Fiscal year 2019: $117.87 million | Fiscal year 2018: $125.59 million | Fiscal year 2017: $126.44 million | Fiscal year 2016: $113.87 million | Fiscal year 2015: $99.49 million | Fiscal year 2014: $83.57 million | Fiscal year 2013: $53.90 million | Fiscal year 2012: $19.52 million | Fiscal year 2011: $11.35 million | Fiscal year 2010: $5.95 million | Fiscal year 2009: $10.84 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: